Literature DB >> 17761884

Strand-biased spreading of mutations during somatic hypermutation.

Shyam Unniraman1, David G Schatz.   

Abstract

Somatic hypermutation (SHM) is a major means by which diversity is achieved in antibody genes, and it is initiated by the deamination of cytosines to uracils in DNA by activation-induced deaminase (AID). However, the process that leads from these initiating deamination events to mutations at other residues remains poorly understood. We demonstrate that a single cytosine on the top (nontemplate) strand is sufficient to recruit AID and lead to mutations of upstream and downstream A/T residues. In contrast, the targeting of cytosines on the bottom strand by AID does not lead to substantial mutation of neighboring residues. This strand asymmetry is eliminated in mice deficient in mismatch repair, indicating that the error-prone mismatch repair machinery preferentially targets top-strand uracils in a way that promotes SHM during the antibody response.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17761884     DOI: 10.1126/science.1145065

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  27 in total

1.  Error-prone DNA repair activity during somatic hypermutation in shark B lymphocytes.

Authors:  Catherine Zhu; Ellen Hsu
Journal:  J Immunol       Date:  2010-10-04       Impact factor: 5.422

Review 2.  Measurements of spontaneous rates of mutations in the recent past and the near future.

Authors:  Fyodor A Kondrashov; Alexey S Kondrashov
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2010-04-27       Impact factor: 6.237

3.  Genomic uracil homeostasis during normal B cell maturation and loss of this balance during B cell cancer development.

Authors:  Sophia Shalhout; Dania Haddad; Angela Sosin; Thomas C Holland; Ayad Al-Katib; Alberto Martin; Ashok S Bhagwat
Journal:  Mol Cell Biol       Date:  2014-08-25       Impact factor: 4.272

4.  Damage-induced localized hypermutability.

Authors:  Lauranell H Burch; Yong Yang; Joan F Sterling; Steven A Roberts; Frank G Chao; Hong Xu; Leilei Zhang; Jesse Walsh; Michael A Resnick; Piotr A Mieczkowski; Dmitry A Gordenin
Journal:  Cell Cycle       Date:  2011-04-01       Impact factor: 4.534

Review 5.  Regulation of AID, the B-cell genome mutator.

Authors:  Celia Keim; David Kazadi; Gerson Rothschild; Uttiya Basu
Journal:  Genes Dev       Date:  2013-01-01       Impact factor: 11.361

6.  Somatic hypermutation at A/T-rich oligonucleotide substrates shows different strand polarities in Ung-deficient or -proficient backgrounds.

Authors:  Marija Zivojnovic; Frédéric Delbos; Giulia Girelli Zubani; Amélie Julé; Alexandre Alcais; Jean-Claude Weill; Claude-Agnès Reynaud; Sébastien Storck
Journal:  Mol Cell Biol       Date:  2014-04-07       Impact factor: 4.272

7.  Hypermutation at A/T sites during G.U mismatch repair in vitro by human B-cell lysates.

Authors:  Phuong Pham; Ke Zhang; Myron F Goodman
Journal:  J Biol Chem       Date:  2008-09-11       Impact factor: 5.157

8.  Activation-induced deaminase heterozygous MRL/lpr mice are delayed in the production of high-affinity pathogenic antibodies and in the development of lupus nephritis.

Authors:  Chuancang Jiang; Ming Lang Zhao; Marilyn Diaz
Journal:  Immunology       Date:  2008-06-20       Impact factor: 7.397

9.  Immunoglobulin switch mu sequence causes RNA polymerase II accumulation and reduces dA hypermutation.

Authors:  Deepa Rajagopal; Robert W Maul; Amalendu Ghosh; Tirtha Chakraborty; Ahmed Amine Khamlichi; Ranjan Sen; Patricia J Gearhart
Journal:  J Exp Med       Date:  2009-05-11       Impact factor: 14.307

10.  Switch recombination and somatic hypermutation are controlled by the heavy chain 3' enhancer region.

Authors:  Wesley A Dunnick; John T Collins; Jian Shi; Gerwin Westfield; Clinton Fontaine; Paul Hakimpour; F Nina Papavasiliou
Journal:  J Exp Med       Date:  2009-11-02       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.